An epithelial marker promoter induction screen identifies histone deacetylase inhibitors to restore epithelial differentiation and abolishes anchorage independence growth in cancers.
about
A new dimension in drug discovery: reversing epithelial-mesenchymal transition (EMT).Pharmacological and immunological targeting of tumor mesenchymalization.The EMT spectrum and therapeutic opportunities.HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells.HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal.
P2860
An epithelial marker promoter induction screen identifies histone deacetylase inhibitors to restore epithelial differentiation and abolishes anchorage independence growth in cancers.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
An epithelial marker promoter ...... ndependence growth in cancers.
@ast
An epithelial marker promoter ...... ndependence growth in cancers.
@en
type
label
An epithelial marker promoter ...... ndependence growth in cancers.
@ast
An epithelial marker promoter ...... ndependence growth in cancers.
@en
prefLabel
An epithelial marker promoter ...... ndependence growth in cancers.
@ast
An epithelial marker promoter ...... ndependence growth in cancers.
@en
P2093
P2860
P1433
P1476
An epithelial marker promoter ...... ndependence growth in cancers.
@en
P2093
J P Thiery
Ry-J Huang
P2860
P2888
P356
10.1038/CDDISCOVERY.2016.41
P577
2016-06-13T00:00:00Z